Venus Remedies gets market authorisation for Bleomycin 15,000 IU in the UK
Venus Remedies holds a total of 15 MA for Bleomycin products across the globe
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
market authorisation
SII seeks market authorisation from DCGI for India’s first qHPV vaccine against cervical cancer
The firm has applied for market authorisation after completing the phase-II/III clinical trial with support of the Department of…